Cargando…

Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance

Antimicrobial resistance (AMR) is a major public health problem threatening to reverse the progress made against infectious diseases. The rapid increase of AMR exposes Italian hospitals at increased risk of untreatable infections. Vaccinations can potentially limit AMR by reducing the number of infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchetti, Federico, Prato, Rosa, Viale, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828092/
https://www.ncbi.nlm.nih.gov/pubmed/34591738
http://dx.doi.org/10.1080/21645515.2021.1969853
_version_ 1784647783089700864
author Marchetti, Federico
Prato, Rosa
Viale, Pierluigi
author_facet Marchetti, Federico
Prato, Rosa
Viale, Pierluigi
author_sort Marchetti, Federico
collection PubMed
description Antimicrobial resistance (AMR) is a major public health problem threatening to reverse the progress made against infectious diseases. The rapid increase of AMR exposes Italian hospitals at increased risk of untreatable infections. Vaccinations can potentially limit AMR by reducing the number of infected cases in need of antibiotics. We conducted a survey among Italian vaccine experts to record their opinion regarding the role of vaccinations against antibiotic resistance (ABR). Among 80 invited experts, 51 answered all questions. Most respondents were experts in hygiene and preventive medicine (56.9%) and aged >50 years (72.6%). ABR was a priority concern in the daily professional activity of 82.4% of respondents. Overall, 47.1% of respondents believed that all vaccinations included in the vaccination calendar played a role against ABR: 92.2% for pertussis vaccination followed by 88.2%, 74.5%, and 70.6% for meningococcus, measles, and varicella vaccinations, respectively. Almost all respondents agreed that the role of vaccinations against ABR should be clearly expressed in the national vaccination guidelines (96.1%) and Scientific Societies should take an explicit position on the issue (92.2%). These results show that Italian experts have recognized the vaccinations’ potential role in limiting ABR and guidelines from the appropriate scientific and governmental authorities are needed.
format Online
Article
Text
id pubmed-8828092
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88280922022-02-10 Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance Marchetti, Federico Prato, Rosa Viale, Pierluigi Hum Vaccin Immunother Short Report Antimicrobial resistance (AMR) is a major public health problem threatening to reverse the progress made against infectious diseases. The rapid increase of AMR exposes Italian hospitals at increased risk of untreatable infections. Vaccinations can potentially limit AMR by reducing the number of infected cases in need of antibiotics. We conducted a survey among Italian vaccine experts to record their opinion regarding the role of vaccinations against antibiotic resistance (ABR). Among 80 invited experts, 51 answered all questions. Most respondents were experts in hygiene and preventive medicine (56.9%) and aged >50 years (72.6%). ABR was a priority concern in the daily professional activity of 82.4% of respondents. Overall, 47.1% of respondents believed that all vaccinations included in the vaccination calendar played a role against ABR: 92.2% for pertussis vaccination followed by 88.2%, 74.5%, and 70.6% for meningococcus, measles, and varicella vaccinations, respectively. Almost all respondents agreed that the role of vaccinations against ABR should be clearly expressed in the national vaccination guidelines (96.1%) and Scientific Societies should take an explicit position on the issue (92.2%). These results show that Italian experts have recognized the vaccinations’ potential role in limiting ABR and guidelines from the appropriate scientific and governmental authorities are needed. Taylor & Francis 2021-09-30 /pmc/articles/PMC8828092/ /pubmed/34591738 http://dx.doi.org/10.1080/21645515.2021.1969853 Text en © 2021 GlaxoSmithKline Biologicals SA. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Marchetti, Federico
Prato, Rosa
Viale, Pierluigi
Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title_full Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title_fullStr Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title_full_unstemmed Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title_short Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title_sort survey among italian experts on existing vaccines’ role in limiting antibiotic resistance
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828092/
https://www.ncbi.nlm.nih.gov/pubmed/34591738
http://dx.doi.org/10.1080/21645515.2021.1969853
work_keys_str_mv AT marchettifederico surveyamongitalianexpertsonexistingvaccinesroleinlimitingantibioticresistance
AT pratorosa surveyamongitalianexpertsonexistingvaccinesroleinlimitingantibioticresistance
AT vialepierluigi surveyamongitalianexpertsonexistingvaccinesroleinlimitingantibioticresistance